Tissue engineering

A UK research team has pioneered a novel technique for engineering tissues which has the capacity to greatly reduce the time taken to fabricate implantable human tissue.

A research team from the UCL Tissue Repair and Engineering Centre (TREC), the UCL Eastman Dental Institute and the UCL Institute of Orthopaedics, has pioneered a novel technique for engineering tissues, which has the capacity to greatly reduce the time taken to fabricate implantable human tissue.

Tissue engineering is a method whereby the patient has cells extracted from his or her body and grown under laboratory conditions for a myriad of applications such as cartilage, skin grafts, heart valves and tendons, without the risk of rejection, infection or the ethical dilemma involved in transplanting a donated organ.

Current tissue engineering methods depend on the ability of the cultured cells themselves to grow new tissue around a cell scaffold, which is slow, expensive and has limited success. Professor Brown’s process is cell-independent, the controlled engineering of scaffolds is achieved by rapidly removing fluid from hyper-hydrated collagen gels.

The fluid is removed by employing plastic compression, a process that the team found produces dense, cellular, mechanically strong collagen structures that can be controlled at nano and micro scales and which mimic biochemical processes.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of premium content. Register for free to unlock unlimited access to all of our premium content, as well as the latest technology news, industry opinion and special reports. 

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox